BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

BD (Becton, Dickinson and Company) announced the CE Mark application for its Liverty™ TIPS Stent Graft, introducing a next-generation, adjustable-diameter device for portal hypertension care in the European Union. This innovation aims to expand treatment options for patients with advanced liver disease and cirrhosis. Safety and effectiveness data from the pivotal ARCH clinical trial for the Liverty™ TIPS Stent Graft will be presented for the first time at the Society of Interventional Radiology Annual Scientific Meeting on April 12, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin